ReviewJournal of materials chemistry. B2026
Microneedle-based platforms for wound healing: recent advances.
Review in Journal of materials chemistry. B, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic and complex wounds remain a major clinical challenge due to persistent inflammation, infection, impaired angiogenesis, and dysregulated immune responses. In response, microneedle (MN) technology has emerged as a minimally invasive, highly versatile platform for wound healing by enabling direct delivery of therapeutics into viable tissue while also supporting wound monitoring and microenvironment modulation. Moreover, advances in MN fabrication techniques, such as micromolding, 3D printing, and centrifugal drawing, enable precise control over needle geometry, mechanical strength, and drug-loading strategies. Diverse MN designs, including dissolvable, swellable, porous, hollow, separable, and multifunctional types, have consequently expanded therapeutic functionality beyond passive drug delivery to encompass immunomodulation, antimicrobial action, angiogenesis, neurovascular regeneration, antioxidative protection, and scar remodeling. Further, intelligent MN systems combine biosensing with stimuli-responsive drug release, enabling real-time monitoring and on-demand therapy tailored to the changing wound environment. This review summarizes recent advances in MN fabrication methods, structural designs, and integration with other scaffolds. It also discusses diagnostic and sensing capabilities, as well as therapeutic mechanisms across diverse wound types, highlighting the translational potential of multifunctional MN systems for next-generation wound care.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.